Jinghong Zhao

5.1k total citations
156 papers, 3.5k citations indexed

About

Jinghong Zhao is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinghong Zhao has authored 156 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Nephrology, 49 papers in Molecular Biology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinghong Zhao's work include Chronic Kidney Disease and Diabetes (33 papers), Parathyroid Disorders and Treatments (21 papers) and Dialysis and Renal Disease Management (19 papers). Jinghong Zhao is often cited by papers focused on Chronic Kidney Disease and Diabetes (33 papers), Parathyroid Disorders and Treatments (21 papers) and Dialysis and Renal Disease Management (19 papers). Jinghong Zhao collaborates with scholars based in China, United States and France. Jinghong Zhao's co-authors include Jiachuan Xiong, Ke Yang, Junping Wang, Yunjian Huang, Ting He, Jingbo Zhang, Tangli Xiao, Ling Nie, Yinghui Huang and Xu Guan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jinghong Zhao

147 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinghong Zhao China 35 1.3k 1.3k 412 411 391 156 3.5k
Yasuhiro Akai Japan 25 1.7k 1.3× 1.1k 0.8× 441 1.1× 540 1.3× 315 0.8× 79 3.8k
Zhangsuo Liu China 37 1.7k 1.3× 1.5k 1.1× 362 0.9× 312 0.8× 454 1.2× 171 4.1k
Raúl R. Rodrigues-Díez Spain 31 1.2k 1.0× 746 0.6× 431 1.0× 228 0.6× 504 1.3× 72 3.1k
Sandra Rayego‐Mateos Spain 31 1.3k 1.0× 951 0.7× 325 0.8× 187 0.5× 524 1.3× 72 3.1k
Takashi Yokoo Japan 30 1.6k 1.3× 1.3k 1.0× 953 2.3× 313 0.8× 355 0.9× 374 4.1k
Hua Su China 27 1.1k 0.8× 1.2k 0.9× 568 1.4× 226 0.5× 381 1.0× 82 4.1k
Niansong Wang China 38 1.9k 1.4× 1.6k 1.2× 583 1.4× 292 0.7× 471 1.2× 193 4.6k
Seong Kwon South Korea 32 774 0.6× 1.1k 0.9× 485 1.2× 292 0.7× 230 0.6× 243 3.4k
Haiping Mao China 33 1.2k 1.0× 1.6k 1.2× 495 1.2× 188 0.5× 305 0.8× 132 3.5k
Julia Carracedo Spain 37 1.0k 0.8× 981 0.8× 434 1.1× 559 1.4× 983 2.5× 94 3.5k

Countries citing papers authored by Jinghong Zhao

Since Specialization
Citations

This map shows the geographic impact of Jinghong Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinghong Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinghong Zhao more than expected).

Fields of papers citing papers by Jinghong Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinghong Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinghong Zhao. The network helps show where Jinghong Zhao may publish in the future.

Co-authorship network of co-authors of Jinghong Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jinghong Zhao. A scholar is included among the top collaborators of Jinghong Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinghong Zhao. Jinghong Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xin, Yaqin Wang, Ai-Hong Zhang, et al.. (2025). Targeting NINJ1-Mediated Plasma Membrane Rupture in Tubular Epithelial Cell Prevents Inflammatory Response in Acute Kidney Injury. International Journal of Biological Sciences. 21(12). 5223–5239.
2.
Liu, Liang, Liu Zhang, Daohai Zhang, et al.. (2025). Risk prediction of cardiovascular events in peritoneal dialysis patients. BMC Nephrology. 26(1). 177–177.
3.
Wang, Xin, Jie Zhou, Yuzhu Peng, et al.. (2024). SREBP1c‐Mediated Transcriptional Repression of YME1L1 Contributes to Acute Kidney Injury by Inducing Mitochondrial Dysfunction in Tubular Epithelial Cells. Advanced Science. 12(6). e2412233–e2412233. 3 indexed citations
4.
Xiong, Jiachuan, et al.. (2024). Macrophage-Derived Type 1 IFN, Renal Tubular Epithelial Cell Polyploidization, and AKI-to-CKD Transition. Journal of the American Society of Nephrology. 36(5). 766–780. 2 indexed citations
5.
Chen, Yin, Jing Chen, Ai-Hong Zhang, et al.. (2024). Self‐Assembling P38 Peptide Inhibitor Nanoparticles Ameliorate the Transition from Acute to Chronic Kidney Disease by Suppressing Ferroptosis. Advanced Healthcare Materials. 13(23). e2400441–e2400441. 6 indexed citations
6.
Wang, Siyang, Jun Liang, & Jinghong Zhao. (2024). A Case of High-Altitude Renal Syndrome. High Altitude Medicine & Biology. 25(2). 149–151.
7.
8.
Liu, Chi, Xiaoqin Tan, Wenmin Yang, et al.. (2023). Proenkephalin-A secreted by renal proximal tubules functions as a brake in kidney regeneration. Nature Communications. 14(1). 7167–7167. 5 indexed citations
9.
Yu, Ting, Xiaoqin Tan, Da‐Qing Jin, et al.. (2023). Renal interstitial cells promote nephron regeneration by secreting prostaglandin E2. eLife. 12. 12 indexed citations
10.
Xiong, Jiachuan & Jinghong Zhao. (2023). Pyroptosis: The Determinator of Cell Death and Fate in Acute Kidney Injury. SHILAP Revista de lepidopterología. 10(2). 118–131. 7 indexed citations
11.
Chen, Jing, Yinghui Huang, & Jinghong Zhao. (2023). [Trimethylamine N-Oxide Induces Renal Fibrosis Through the PI3K/AKT/SREBP1 Pathway].. PubMed. 54(6). 1105–1111. 2 indexed citations
12.
Wang, Shaobo, Yin Chen, Songling Han, et al.. (2022). Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway. Theranostics. 12(8). 3882–3895. 100 indexed citations
13.
Yang, Wenmin, et al.. (2021). Establishment of a Drug Screening Model for Cardiac Complications of Acute Renal Failure. Biomolecules. 11(9). 1370–1370. 6 indexed citations
14.
Li, Daixi, Cheng Wang, Shaobo Wang, et al.. (2021). Discovery of a Natural Product with Potent Efficacy Against SARS-CoV-2 by Drug Screening. Interdisciplinary Sciences Computational Life Sciences. 14(1). 55–63. 5 indexed citations
15.
Wang, Cheng, Shaobo Wang, Yin Chen, et al.. (2021). Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection. ACS Nano. 15(4). 6340–6351. 66 indexed citations
17.
Ma, Tiantian, Zhikai Yang, Sainan Zhu, et al.. (2020). Pramipexole in peritoneal dialysis patients with restless legs syndrome (RLS): a protocol for a multicentre double-blind randomised controlled trial. BMJ Open. 10(2). e033815–e033815. 1 indexed citations
18.
Zhang, Ying, Shaobo Wang, Yinghui Huang, et al.. (2019). Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin. Molecular Medicine Reports. 21(1). 393–404. 14 indexed citations
19.
Zhao, Jinghong. (2019). Mesangial Cells and Renal Fibrosis. Advances in experimental medicine and biology. 1165. 165–194. 83 indexed citations
20.
Wang, Yiqin, et al.. (2019). Hypomagnesemia and Short-Term Mortality in Elderly Maintenance Hemodialysis Patients. Kidney Diseases. 6(2). 109–118. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026